Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

7/31/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (June 2018)

Between January and June 2018, Russia produced 157.4 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.2% lower than that of the same period of 2017. In physical terms, Russia produced 2 bln units of pharmaceuticals over the period, which is 10% lower than that of the same period of 2017. If calculated in minimum dosage units (MDU), the dynamics are +0.6%. The dynamics of the production of over-the-counter drugs in physical terms are -9%, while those of the Rx production are -11%. In June, the dynamics of the OTC production were +4.5%, while those of the Rx production were -19%.

7/31/2018 Database Update: Pharmaceutical Drug Import from EEU Countries to Russia (June 2018)

Between January and June 2018, Russia imported 5.9 bln RUB worth of pharmaceutical drugs produced in the EEU countries (wholesale prices, VAT included), which is in monetary terms more than 11% higher than that of the same period of 2017. In physical terms, Russia imported 99.7 mln units of drugs, which is 4.3% lower than that of the same period of 2017.

7/27/2018 Database Update: API Import to Russia (May 2018)

Between January and May 2018, Russia imported 37.7 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 34% higher than that of the same period of 2017. In physical terms, the dynamics are -3.3%, with the import amounting to 4,600 tons of APIs.

7/27/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (May 2018)

Between January and May 2018, Russia imported 24.8 bln RUB worth of veterinary products (free circulation prices): 13.6 bln RUB of feed supplements (+13% in monetary terms), 10.4 bln RUB of veterinary drugs (+15%), and 0.83 bln RUB of veterinary APIs (+26%).

7/25/2018 Database Update: Pharmaceutical Drug Import to Russia (May 2018)

Between January and May 2018, Russia imported 198.7 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 2% higher than that of the same period of 2017, and 42.7 bln RUB worth of in-bulk pharmaceutical drugs, which is in monetary terms 20.3% higher than that of the same period of 2017. The total dynamics are 4.8%.

All news [104]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.